首页> 外文OA文献 >Clinical outcomes after early ambulatory multidrug therapy for high-risk SARS-CoV-2 (COVID-19) infection

【2h】

Clinical outcomes after early ambulatory multidrug therapy for high-risk SARS-CoV-2 (COVID-19) infection

机译：高危SARS-COV-2（Covid-19）感染后早期动态多药治疗后的临床结果

代理获取

本网站仅为用户提供外文OA文献查询和代理获取服务，本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文，但由于OA文献来源多样且变更频繁，仍可能出现获取不到、文献不完整或与标题不符等情况，如果获取不到我们将提供退款服务。请知悉。

页面导航

著录项
引文网络
相似文献
相关主题

著录项

作者

展开▼
作者单位

展开▼
年度 2020
总页数
原文格式 PDF
正文语种
中图分类

相似文献

外文文献
中文文献
专利

1. The Australasian COVID-19 Trial (ASCOT) to assess clinical outcomes in hospitalised patients with SARS-CoV-2 infection (COVID-19) treated with lopinavir/ritonavir and/or hydroxychloroquine compared to standard of care: A structured summary of a study protocol for a randomised controlled trial [J] . Justin T. Denholm, Joshua Davis, David Paterson, Trials . 2020,第1期

机译：澳大利亚Covid-19试验（ASCOT）评估住院治疗的SARS-COV-2感染（Covid-19）的临床结果与Lopinavir / Ritonavir和/或羟氯喹与护理标准进行治疗：研究方案的结构化概述对于随机对照试验
2. Effectiveness of a multidrug therapy consisting of Ivermectin, Azithromycin, Montelukast, and Acetylsalicylic acid to prevent hospitalization and death among ambulatory COVID-19 cases in Tlaxcala, Mexico [J] . René Lima-Morales, Pablo Méndez-Hernández, Yvonne N. Flores, International journal of infectious diseases : . 2021,第a期

机译：由伊维菌素，阿奇霉素，孟加斯特和乙酰胱氨酸和乙酰胱氨酸组成的多药治疗的有效性，以防止在墨西哥坦克萨拉的动态巢穴-19例中住院和死亡
3. Colistin therapy for multidrug-resistant Gram-negative infection: Clinical outcome and risk factors [J] . JunY.H., JeunS.J., KangS.H., Infection . 2013,第6期

机译：Colistin治疗多药耐药革兰氏阴性菌感染：临床结果和危险因素
4. The Clinical Outcome of Infections Due to Extended Spectrum β-Lactamase Producing (ESBL) Enterobacteriaceae [C] . Perovic O., Brink A., Richards G., International Congress of Chemotherapy and Infection . 2009

机译：扩展β-内酰胺酶产生（ESBL）肠杆菌的感染临床结果
5. Immunotherapy Improves Outcomes by Ameliorating Inflammation during Infections Caused by Gram-Negative Bacteria [D] . Nielsen, Travis Brady. 2018

机译：免疫疗法通过改善由革兰阴性细菌引起的感染炎症改善炎症的结果
6. The Australasian COVID-19 Trial (ASCOT) to assess clinical outcomes in hospitalised patients with SARS-CoV-2 infection (COVID-19) treated with lopinavir/ritonavir and/or hydroxychloroquine compared to standard of care: A structured summary of a study protocol for a randomised controlled trial [O] . Justin T. Denholm, Joshua Davis, David Paterson, -1

机译：澳洲COVID-19试验（ASCOT）以洛匹那韦/利托那韦和/或羟氯喹治疗的SARS-CoV-2感染住院患者（COVID-19）与护理标准进行比较以评估其临床结局：研究方案的结构概要用于随机对照试验
7. Multifaceted highly targeted sequential multidrug treatment of early ambulatory high-risk SARS-CoV-2 infection (COVID-19) [O] . 2020

机译：早期动态高风险SARS-COV-2感染的多方面高度靶向序列多药处理（Covid-19）

Clinical outcomes after early ambulatory multidrug therapy for high-risk SARS-CoV-2 (COVID-19) infection

著录项

引文网络

相似文献

相关主题

期刊订阅